Citius Pharmaceuticals Inc (CTXR) support and resistance · rev $7.1M
Citius Pharmaceuticals Inc (CTXR) is a biotechnology company listed on US.
This page maps Citius Pharmaceuticals Inc (CTXR) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported CTXR revenue for 2026-06-30 was $7.1M. Net income was -$49.4M. Revenue was up 26.6% from 2026-03-31 to 2026-06-30. CTXR currently screens at market cap $13.4M.
CTXR currently screens at market cap $13.4M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new CTXR 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the CTXR quote page for the session range and the stock page for the full model.
Not investment advice.